Our efforts ensure the needs, values and preferences of the patient are represented
Jeff has over 20 years experience creating award-winning web and mobile businesses. Jeff is a passionate innovator who utilizes emerging technologies to start companies that creatively fill gaps in existing markets. He specializes in startup environments at the conception stage where ideas become products and teams are assembled to bring those products to market. Companies include ViciNFT, JB3 Industrial, CrowdOptic, LoanHounds (acquired by QuinStreet), StockPoint (acquired by Pinnacor).
Executive improving healthcare through the development of new products and services by integrating technology, big data, and advanced data analytics. Developed and launched first electronic home-based motor test battery trial for Parkinson’s disease in partnership with Intel and scientists worldwide. Director of Data Science The Michael J. Fox Foundation for Parkinson’s Research. University of California, Berkeley. Stanford University Graduate School of Business. CEO of RosettaMD, Managing Director Kinetics.
As a Digital Biomarker Advisor at Beneufit, Professor Shah will leverage his deep understanding of paediatric gastrointestinal health to guide the development of cutting-edge digital biomarkers. Neil was involved in the development of national and international guidelines for the identification and treatment of reflux, milk and GI food allergy. Neil has published over 200 peer reviewed medical articles. He has held positions at University College London (UK), The Katholoic University Leuven ( Belgium) and, Great Ormond Street Children's Hospital (UK). He has worked for several years in Industry with FTSE 100 companies as Global medical/innovation lead in the fields of medical sciences and Nutrition.
Ugenteraan is leading the charge in our mission to pioneer digital biomarkers, with a robust background in machine learning and a passion for transforming healthcare. As our leading machine learning engineer, Ugenteraan is at the forefront of developing advanced algorithms that analyze smartphone video to uncover invaluable insights. He leads the effort to create digital biomarkers that hold the potential to revolutionize patient care. CTO Ombre, Senior AI Engineer Digi Telecommunications.
Dr. Lisk is a published, board certified neurologist with a fellowship in movement disorders. He is an investigator in over twenty national clinical research trials in Parkinson’s disease. Memberships include The American Academy of Neurology Digital Strategy Subcommittee, Texas Health Services Authority Board of Directors, The Movement Disorder Society, California State Athletic Commission. Board of Directors of the American Heart Association African-American Task Force, Alzheimer’s Association Board Member and 2010 NAACP Man of Valor Award.
Board-certified toxicologist specializing in the nonclinical development of small and large molecule therapeutics. She has directed toxicology, pharmacokinetics, bioanalytical development and animal resources groups, lead project teams and subteams, and mentored many scientists. She has experience defending nonclinical development plans to US, EU and Japanese regulatory authorities. Sangamo BioSciences, BioMarin, XOMA, Elan Pharmaceuticals.